MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1
Abstract Background Anaplastic thyroid cancer (ATC) is considered to be a rare type of thyroid cancer but takes up the most important proportion of thyroid cancer-related deaths. Therefore, the development of molecular targeted therapy is an exciting strategy in the management of ATC. Methods miR-15...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2019-11-01
|
| Edice: | BMC Cancer |
| Témata: | |
| On-line přístup: | http://link.springer.com/article/10.1186/s12885-019-6319-4 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|